127 related articles for article (PubMed ID: 1933807)
1. Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival.
Levin I; Klein T; Goldstein J; Kuperman O; Kanetti J; Klein B
Cancer; 1991 Dec; 68(12):2591-4. PubMed ID: 1933807
[TBL] [Abstract][Full Text] [Related]
2. Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma.
Tomita Y; Matsumoto Y; Nishiyama T; Fujiwara M
J Pathol; 1990 Oct; 162(2):157-64. PubMed ID: 2250194
[TBL] [Abstract][Full Text] [Related]
3. Expression of HLA class I-encoded cell surface antigens in transitional cell carcinoma of the urinary bladder.
Levin I; Klein B; Segal S; Eyal A; Gopas J; Kaneti J; Saadon M; Kuperman O
Tissue Antigens; 1992 Jan; 39(1):19-22. PubMed ID: 1542872
[No Abstract] [Full Text] [Related]
4. Association between HLA antigens and bladder tumors.
Tokuç R; Akdaş A; Ozerkan K; Remzi D
Eur Urol; 1987; 13(3):207-9. PubMed ID: 3497040
[TBL] [Abstract][Full Text] [Related]
5. Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment.
Stefanini GF; Bercovich E; Mazzeo V; Grigioni WF; Emili E; D'Errico A; Lo Cigno M; Tamagnini N; Mazzetti M
J Urol; 1989 Jun; 141(6):1449-53. PubMed ID: 2657113
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.
Gan LH; Huang LF; Zhang X; Lin A; Xu DP; Wang Q; Wang TJ; Yan WH
Hum Immunol; 2010 Sep; 71(9):899-904. PubMed ID: 20600448
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
8. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
[TBL] [Abstract][Full Text] [Related]
9. Histocompatibility testing in patients with carcinoma of the bladder.
Lytton B; O'Toole C; Tiptaft R; Festenstein H; Batchelor JR
Cancer; 1983 Aug; 52(4):645-7. PubMed ID: 6574806
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
11. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
12. HLA-A, B and DR in Caucasians with transitional cell carcinoma of the bladder.
Saunders PH; Anderson SA; Stogdill VD; Lamm DL
Tissue Antigens; 1983 Nov; 22(5):389-92. PubMed ID: 6581580
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
Parham DM; Morton K; Coghill G; Robertson AJ; Kerr MA
J Clin Pathol; 1990 Jul; 43(7):541-3. PubMed ID: 1974266
[TBL] [Abstract][Full Text] [Related]
14. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder.
Takashi M; Murase T; Kinjo T; Mitsuya H; Nagura H
Urol Int; 1987; 42(3):170-5. PubMed ID: 3303592
[TBL] [Abstract][Full Text] [Related]
15. [The study of the ABH isoantigen of bladder tumors].
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
[TBL] [Abstract][Full Text] [Related]
16. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-G in cancer bladder.
El-Chennawi FA; Auf FA; El-Diasty AM; El-Daim MA; El-Sherbiny SM; Ali A; El-Baz M; El-Hameed MA; Paul P; Ibrahim EC; Carosella E; Ghoneim MA
Egypt J Immunol; 2005; 12(1):57-64. PubMed ID: 16734140
[TBL] [Abstract][Full Text] [Related]
18. Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression.
Langkilde NC; Wolf H; Clausen H; Kjeldsen T; Orntoft TF
Cancer; 1992 Jan; 69(1):219-27. PubMed ID: 1727666
[TBL] [Abstract][Full Text] [Related]
19. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
[No Abstract] [Full Text] [Related]
20. Types of HLA in the bladder transitional cell carcinoma (TCC).
Yılmaz E; Uğur Özalp A; Cekmen A; Eren B; Onal B; Akkuş E; Erdoğan E
Med Glas (Zenica); 2013 Feb; 10(1):133-6. PubMed ID: 23348175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
